Stories about breast cancer that can inspire and inform

Blog  |  Newsroom

Breast Cancer Breakthroughs Episode 9 – New Frontiers in Early ER-Positive Breast Cancer 

Researchers are exploring new frontiers in early estrogen receptor-positive (ER+) breast cancer to improve outcomes and quality of life for patients. People with early ER+ breast cancer often see favorable outcomes from their treatment, but once treatment is done, many face the fear of not knowing if their cancer will come back.

Spotlight on Clinical Trials: Shining a Light on Breast Cancer Disparities

“In the Black community, there’s a stigma about treatment, clinical trials and research. We have to understand that there’s not enough data to help us if we get sick. There’s not enough data to create treatments that will help us. We need to participate in clinical trials.” Sharon Elmore-Anderson Patient Advocate Living with Metastatic IBC 

Shining a Spotlight on Clinical Trials

Sheila Johnson had never planned to be a fierce advocate for clinical trials, but her life took a dramatic turn when she lost her mother to metastatic breast cancer (MBC) in 2004. Just five years later, she found that she also had MBC when her doctor found the burning sensation she felt was the result of a tumor pressing against the wall of her chest. At the time of her diagnosis, the tumor had already spread to her ribs and liver. Following multiple rounds of chemotherapy, Sheila’s doctor offered her another option. 

Breast Cancer Breakthroughs Episode 8: Navigating Breast Cancer Recurrence 

After the initial shock of a breast cancer diagnosis, patients with early breast cancer are immediately faced with important decisions about their treatment plan, including how to manage their risk of recurrence. As they navigate a modern landscape of treatment options, these patients must also make decisions that could dramatically impact their quality of life.

Understanding Diet and Breast Cancer Risk 

The connection between diet and breast cancer risk has been studied extensively over the past 20 years. According to the American Cancer Society, improved lifestyle habits, including a healthier diet may reduce the risk of many cancers, including breast cancer. As everyday consumers, we know a healthy diet can improve our overall physical fitness, as well as our energy levels and mental stamina, but can it also help reduce our breast cancer risk?

Komen Has Helped Pave the Way for 19 FDA-Approved Breast Cancer Drugs

“Over the past 10 years, 19 FDA-approved breast cancer drugs have a connection to Komen. “We are able to show the points along the research pathway for each of the 19 drugs where Komen funding has helped in development and eventual clinical use, either through investments in direct studies or investments in people doing the research,” said Dana Brantley-Sieders.

Breast Cancer Breakthroughs Episode 7: Bringing Treatments to Life 

One of the greatest challenges today in treating breast cancer is that tumor cells can evolve and change over time and become resistant to treatment. This treatment resistance is caused by mutations, or changes to the blueprint of a tumor cell’s DNA that allow it to adapt and survive. As a result, a treatment that was working well for a patient suddenly becomes ineffective. 

Komen Grantee Dr. Eileen Morgan and Collaborators Pinpoint Opportunities to Improve Early Breast Cancer Diagnosis in New Study 

In a paper published in JAMA Oncology, Susan G. Komen grantee Eileen Morgan, Ph.D., and her team at the International Agency for Research on Cancer (IARC) studied how the stage at diagnosis of breast cancer differed in 81 countries across the globe. In this international collaborative effort, researchers reviewed studies that used population-based cancer registry data on over 2 million women, which allowed the research team to compare stage at diagnosis across various countries, age groups and socioeconomic backgrounds.